Cellosaurus

DOI=10.1007/978-1-4757-1647-4_13
Biedler J.L.
Chromosome abnormalities in human tumor cells in culture.
(In) Human tumor cells in vitro; Fogh J. (eds.); pp.359-394; Springer; New York (1975)

PubMed=8667638
Hu Z.-B., Ma W., Zaborski M., MacLeod R.A.F., Quentmeier H., Drexler H.G.
Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
Leukemia 10:1025-1040(1996)

PubMed=9096695; DOI=10.1038/sj.leu.2400621
Drexler H.G., Zaborski M., Quentmeier H.
Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.
Leukemia 11:541-551(1997)

PubMed=12091369; DOI=10.1182/blood.V100.2.701
Masterson A.J., Sombroek C.C., De Gruijl T.D., Graus Y.M.F., van der Vliet H.J.J., Lougheed S.M., van den Eertwegh A.J.M., Pinedo H.M., Scheper R.J.
MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors.
Blood 100:701-703(2002)

PubMed=16408098; DOI=10.1038/sj.leu.2404081
Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.
Leukemia 20:471-476(2006)

PubMed=16423051; DOI=10.1111/j.1365-2567.2005.02274.x
Larsson K., Lindstedt M., Borrebaeck C.A.
Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells.
Immunology 117:156-166(2006)

PubMed=17533051; DOI=10.1016/j.exphem.2007.03.003
Ciraci E., Barisani D., Parafioriti A., Formisano G., Arancia G., Bottazzo G., Berardi A.C.
CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts.
Exp. Hematol. 35:967-977(2007)

Patent=US8455253
Goletz S., Scheper R.J., Masterson A.J., Pinedo H.M.
Differentiation of MUTZ-3 cells to produce effective dendritic cells.
Patent number US8455253, 04-Jun-2013